Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 1998, p. 2144-2145, Vol. 42, No. 8
Department of Molecular Genetics, The Ohio
State University, Columbus, Ohio 43210,1 and
Tennent Institute of Ophthalmology, Western Infirmary,
Glasgow University, Glasgow, United Kingdom2
Received 10 April 1998/Returned for modification 5 May
1998/Accepted 10 June 1998
DNA sequences of three 18S rRNA gene alleles present in
trophozoites obtained before and after therapy for
Acanthamoeba keratitis substantiate a previous report that
the infection was due to a single Acanthamoeba strain.
Thus, the possibility that propamidine resistance which developed
during therapy was due to a mixed infection was ruled out.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Confirmatory Evidence from 18S rRNA Gene Analysis for In Vivo
Development of Propamidine Resistance in a Temporal Series of
Acanthamoeba Ocular Isolates from a Patient

*
Corresponding author. Mailing address: Department of
Molecular Genetics, The Ohio State University, 484 W. 12th Ave.,
Columbus, OH 43210-1292. Phone: (614) 292-5963. Fax: (614) 292-4466. E-mail: byers.2{at}osu.edu.
Present address: Department of Genetics, University of
Pennsylvania, Stellar Chance Labs, Philadelphia, PA 19104.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |